Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 25;8(5):e2832. doi: 10.1038/cddis.2016.482

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 The Author(s)

Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Effect of our model on SDF-1 levels in the lungs of mice (a). Mice inhaled LPS and SDF-1 levels were determined in the lungs (n=8) and BAL (n=4). Data are presented as mean ±S.D.; *P<0.05 versus without LPS. Time optimum for the administration of the CXCR4- (b) and CXCR7-antagonist (c). The inhibitors were given at indicated time points and, 24 h after LPS-inhalation, migration of PMNs into the different compartments of the lung (IV=intravascular; IS=interstitial; BAL=bronchoalveolar lavage) was evaluated. Data are presented as mean ±S.D.; n≥4; *P<0.05 versus LPS-only treated